Seeking Alpha

  Sarepta Therapeutics, Inc. - NASDAQ

10/1/2014, 6:41 PM ET
  • The Scientist | Send Message 30 Apr 2012

    SRPT has superior RNA technology. ALNY has superior RNA delivery tech (via MIT collaboration). Acquire both and potential is limitless
      SRPT vs. ETF Alternatives
      Company Description
      Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States